Understanding how HIV interacts within cells
Dynamics of HIV Nuclear Interactions
['FUNDING_OTHER'] · SEATTLE CHILDREN'S HOSPITAL · NIH-11307296
This study is looking at how HIV behaves inside infected cells to understand how it hides from the immune system and keeps making copies of itself, which could help develop new treatments for people living with HIV.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SEATTLE CHILDREN'S HOSPITAL (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11307296 on ClinicalTrials.gov |
What this research studies
This research investigates the interactions of HIV within the nucleus of infected cells, focusing on how these dynamics affect the virus's ability to replicate and persist in the body. By using advanced imaging techniques and molecular biology methods, the research aims to uncover the mechanisms that allow HIV to evade the immune system and establish long-term infections. Patients may benefit from insights gained that could lead to new therapeutic strategies targeting these interactions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are seeking new treatment options.
Not a fit: Patients who are not infected with HIV or those who are already on effective antiretroviral therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that more effectively control or eliminate HIV infections.
How similar studies have performed: While the specific dynamics of HIV nuclear interactions are still being explored, similar research approaches have shown promise in understanding viral persistence and could lead to breakthroughs in HIV treatment.
Where this research is happening
SEATTLE, UNITED STATES
- SEATTLE CHILDREN'S HOSPITAL — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ENGELMAN, ALAN N. — SEATTLE CHILDREN'S HOSPITAL
- Study coordinator: ENGELMAN, ALAN N.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.